Found: 16
Select item for more details and to access through your institution.
DNA repair inhibitors sensitize cells differently to high and low LET radiation.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-02719-9
- By:
- Publication type:
- Article
Additive Benefits of Radium-223 Dichloride and Bortezomib Combination in a Systemic Multiple Myeloma Mouse Model.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 11, p. 5570, doi. 10.3390/ijms22115570
- By:
- Publication type:
- Article
Pan-CDK inhibition augments cisplatin lethality in nasopharyngeal carcinoma cell lines and xenograft models.
- Published in:
- Signal Transduction & Targeted Therapy, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41392-018-0010-0
- By:
- Publication type:
- Article
Probing the catalytic functions of Bub1 kinase using the small molecule inhibitors BAY-320 and BAY-524.
- Published in:
- eLife, 2016, p. 1, doi. 10.7554/eLife.12187
- By:
- Publication type:
- Article
Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression.
- Published in:
- Oncogene, 1997, v. 15, n. 6, p. 669, doi. 10.1038/sj.onc.1201219
- By:
- Publication type:
- Article
Synergistic Effect of a Mesothelin Targeted Thorium-227 Conjugate in Combination with DNA Damage Response Inhibitors in Ovarian Cancer Xenograft Models.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.223701
- By:
- Publication type:
- Article
Synergistic Effect of a Mesothelin-Targeted <sup>227</sup>Th Conjugate in Combination with DNA Damage Response Inhibitors in Ovarian Cancer Xenograft Models.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 9, p. 1293, doi. 10.2967/jnumed.118.223701
- By:
- Publication type:
- Article
Differential regulation of in vivo angiogenesis by angiotensin II receptors.
- Published in:
- FASEB Journal, 2003, v. 17, n. 14, p. 2061, doi. 10.1096/fj.03-0129com
- By:
- Publication type:
- Article
Active interaction of human A375 melanoma cells with the lymphatics in vivo.
- Published in:
- Histochemistry & Cell Biology, 2000, v. 114, n. 5, p. 373, doi. 10.1007/s004180000204
- By:
- Publication type:
- Article
Identification of Atuveciclib (BAY 1143572), the First Highly Selective, Clinical PTEFb/CDK9 Inhibitor for the Treatment of Cancer.
- Published in:
- ChemMedChem, 2017, v. 12, n. 21, p. 1776, doi. 10.1002/cmdc.201700447
- By:
- Publication type:
- Article
Modular Assembly of Allosteric MEK Inhibitor Structural Elements Unravels Potency and Feedback-Modulation Handles.
- Published in:
- ChemMedChem, 2015, v. 10, n. 12, p. 2004, doi. 10.1002/cmdc.201500442
- By:
- Publication type:
- Article
The Lab Oddity Prevails: Discovery of Pan-CDK Inhibitor ( R)- S-Cyclopropyl- S-(4-{[4-{[(1 R,2 R)-2-hydroxy-1-methylpropyl]oxy}-5-(trifluoromethyl)pyrimidin-2-yl]amino}phenyl)sulfoximide (BAY 1000394) for the Treatment of Cancer.
- Published in:
- ChemMedChem, 2013, v. 8, n. 7, p. 1067, doi. 10.1002/cmdc.201300096
- By:
- Publication type:
- Article
Cover Picture: The Lab Oddity Prevails: Discovery of Pan-CDK Inhibitor ( R)- S-Cyclopropyl- S-(4-{[4-{[(1 R,2 R)-2-hydroxy-1-methylpropyl]oxy}-5-(trifluoromethyl)pyrimidin-2-yl]amino}phenyl)sulfoximide (BAY 1000394) for the Treatment of Cancer (ChemMedChem 7/2013)
- Published in:
- ChemMedChem, 2013, v. 8, n. 7, p. 1021, doi. 10.1002/cmdc.201390025
- By:
- Publication type:
- Article
Macrocyclic Aminopyrimidines as Multitarget CDK and VEGF-R Inhibitors with Potent Antiproliferative Activities.
- Published in:
- ChemMedChem, 2007, v. 2, n. 1, p. 63, doi. 10.1002/cmdc.200600199
- By:
- Publication type:
- Article
Off-Target Decoding of a Multitarget Kinase Inhibitor by Chemical Proteomics.
- Published in:
- ChemBioChem, 2009, v. 10, n. 7, p. 1163, doi. 10.1002/cbic.200800796
- By:
- Publication type:
- Article
From the Insoluble Dye Indirubin towards Highly Active, Soluble CDK2-Inhibitors.
- Published in:
- ChemBioChem, 2005, v. 6, n. 3, p. 531, doi. 10.1002/cbic.200400108
- By:
- Publication type:
- Article